{
    "success": true,
    "data": {
        "complex": true,
        "leverage": true,
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "synthetic",
        "ucits": false,
        "type": "ETP",
        "complex_factors": [
            "Significant Leverage (3x daily)",
            "Compounding Effect (daily rebalancing)",
            "Implied Derivative Use (to achieve leveraged objective)",
            "Synthetic Replication (implied by collateral funding payment obligations for leveraged return)",
            "Targeted at Sophisticated Investors",
            "KID Comprehension Alert",
            "Not a UCITS product"
        ],
        "classification": "complex",
        "supporting_data": "This product is classified as complex due to multiple factors. Firstly, it is an 'ETP Security' and explicitly not labelled as a UCITS, therefore, the presumption of non-complexity for UCITS ETFs does not apply (MiFID II Rules, point 1; ESMA35-36-1640, pg 8, section Execution-only). Secondly, the product offers '3 times the value of the daily performance' of its reference asset, indicating significant embedded leverage. Rule 5 of the provided framework states that 'Significant leverage beyond UCITS limits (10% temporary borrowing) makes an ETF complex.' This 3x daily leverage is well beyond such limits and is an inherent part of the product's strategy, making derivatives integral to its objective (MiFID II Rules, point 2). The ESMA consultation paper (CESR/09-295, paragraph 7) also states that 'all derivatives are assumed to be complex because their value is derived from another financial instrument or asset, adding a level of complexity to the understanding of the characteristics and valuation of those instruments.' Thirdly, the KID details a 'Compounding Effect' due to 'daily leverage rebalancing,' which means holding the product for more than one day is likely to result in a return different from 3 times the reference asset's return. This phenomenon makes the product's payoff structure opaque and difficult for a retail investor with basic knowledge to understand, reinforcing complexity (MiFID II Rules, point 4).Fourthly, while the replication method is not explicitly stated as 'synthetic with swaps,' the description of 'Collateral Assets' held in a 'Margin Account' used to fund the 'Issueru2019s payment obligations' for a 3x leveraged daily return strongly implies the use of derivatives (such as total return swaps or futures) to achieve its objective. This aligns with the 'Complex' classification under Rule 3 for synthetic replication, where derivatives are central to the strategy and introduce risks like counterparty and collateral risk.Finally, the Key Information Document itself includes a mandatory 'You are about to purchase a product that is not simple and may be difficult to understand' comprehension alert, as required for complex products (MiFID II Rules, point 7). The KID further specifies that the product is 'intended for sophisticated investors' who 'understand the risk of compounded returns and the increased risk of investment in leveraged products,' directly contradicting the criteria for a non-complex product which should be understood by an average retail investor (MiFID II Rules, point 4)."
    }
}